Connection
Shyam Raghavan to Carcinoma, Transitional Cell
This is a "connection" page, showing publications Shyam Raghavan has written about Carcinoma, Transitional Cell.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.174 |
|
|
|
-
Hirotsu KE, Rana J, Wang JY, Raghavan SS, Rieger KE, Srinivas S, Fan AC, Kwong BY, Novoa RA, Zaba LC. Clinicopathologic characterization of enfortumab vedotin-associated cutaneous toxicity in patients with urothelial carcinoma. J Am Acad Dermatol. 2021 12; 85(6):1610-1611.
Score: 0.174